Patent directory · USPTO A61K / A61P
Patents matching “THE REGENTS OF THE UNIVERSITY OF MICHIGAN”
774 pharma patents match "THE REGENTS OF THE UNIVERSITY OF MICHIGAN" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 774 pharmaceutical patents matching "THE REGENTS OF THE UNIVERSITY OF MICHIGAN" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10130560
Bioactive “smart” dental composite materials
granted -
US 10111937
Method of reducing accumulation of intracellular tingible body macrophages
granted -
US 10080790
Staphylococcus aureus materials and methods
granted -
US 10077271
Methods and compositions for inhibiting the interaction of menin with MLL proteins
granted -
US 10071943
Copper catalyzed [18F]fluorination of iodonium salts
granted -
US 10046045
Vaccine compositions and uses thereof
granted -
US 9974844
Cancer vaccine compositions and methods of using the same
granted -
US 9957569
Recurrent gene fusions in prostate cancer
granted -
US 9944652
Deuterated amlexanox
granted -
US 9938582
Recurrent gene fusions in prostate cancer
granted -
US 9931412
Targeted theranostics
granted -
US 9926602
Recurrent gene fusions in prostate cancer
granted -
US 9926372
Methods and compositions for modulation of blood-neural barrier
granted -
US 9919008
Method for treating age-related hearing loss (ARHL)
granted -
US 9913900
Method of treating alvelor bone loss through the use of anti-sclerostin antibodies
granted -
US 9914723
Small molecule inhibitors of Mcl-1 and uses thereof
granted -
US 9889156
Method for treating noise-induced hearing loss (NIHL)
granted -
US 9884841
Small molecule inhibitors of Mcl-1 and uses thereof
granted -
US 9878010
Methods of treating metabolic disorders
granted -
US 9877937
Compounds and methods for treating aberrant adrenocortical cell disorders
granted -
US 9872953
Nitric oxide delivery devices
granted -
US 9868736
Deubiquitinase inhibitors and methods for use of the same
granted -
US 9862746
Compositions and methods relating to hindering DOT1L recruitment by MLL-fusion proteins
granted -
US 9849138
1,4-benzodiazepone-2,5-diones and related compounds with therapeutic properties
granted